ADC Therapeutics SA - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
ADCT New York 2836 www.adctherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for ADC Therapeutics SA

Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year? - Jan 13th, 2026 7:40 am
ADC Therapeutics Provides Preliminary Fourth Quarter and Full Year 2025 Revenue and Cash Estimates and Recent Corporate Updates - Jan 8th, 2026 2:05 pm
ADC Therapeutics to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Jan 8th, 2026 5:15 am
ADC Therapeutics Announces New Employee Inducement Grant - Jan 2nd, 2026 2:05 pm
ADC Therapeutics (ADCT) Upgraded to Buy: Here's Why - Dec 29th, 2025 10:00 am
RBC Capital Bullish on ADC Therapeutics S.A. (ADCT) on Lymphoma Treatment Development - Dec 17th, 2025 11:14 pm
Is ADC Therapeutics (ADCT) Stock Outpacing Its Medical Peers This Year? - Dec 17th, 2025 7:40 am
ADC Therapeutics SA (ADCT) is a Great Momentum Stock: Should You Buy? - Dec 15th, 2025 10:00 am
ADC Therapeutics updates data from Phase 1b trial of Zynlonta in lymphoma - Dec 4th, 2025 5:40 am
ADC Therapeutics Announces Updated Data from LOTIS-7 Phase 1b Clinical Trial of ZYNLONTA® in Combination with Bispecific Antibody Supporting Potential Best-in-Class Regimen in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma - Dec 3rd, 2025 5:30 am
ADC Therapeutics to Provide Update on LOTIS-7 Clinical Trial - Dec 2nd, 2025 2:05 pm
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan - Dec 1st, 2025 2:05 pm
Is ADC Therapeutics (ADCT) Outperforming Other Medical Stocks This Year? - Dec 1st, 2025 7:40 am
ADC Therapeutics (ADCT) Upgraded to Buy: Here's What You Should Know - Nov 18th, 2025 10:00 am
ADC Therapeutics SA (ADCT) Q3 2025 Earnings Call Highlights: Strategic Advances Amid Revenue ... - Nov 10th, 2025 2:01 pm
ADC Therapeutics (ADCT) Earnings Call Transcript - Nov 10th, 2025 7:17 am
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates - Nov 10th, 2025 6:40 am
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update - Nov 10th, 2025 5:30 am
Mettler-Toledo Q3 Earnings Top Estimates, Sales Decline Y/Y - Nov 7th, 2025 10:51 am
Protagonist Therapeutics (PTGX) Reports Q3 Loss, Lags Revenue Estimates - Nov 6th, 2025 3:45 pm